By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Lynx Therapeutics, Inc. 

25861 Industrial Boulevard

Hayward  California  94545  U.S.A.
Phone: 510-670-9300 Fax: 510-670-9302


SEARCH JOBS


Industry
Biotechnology

Segment
Genomics





Company News
Solexa, Inc. (SLXA) Release: Company Builds Management Team To Be A Future Genomics Platform Leader; Peter Lundberg Named VP And Chief Technical Officer10/19/2005 5:13:00 PM
Lynx Therapeutics, Inc. (LYNX) And Solexa Ltd Combine To Become Solexa, Inc. (SLXA); Company Plans To Dramatically Reduce Cost Of Whole Genome DNA Sequencing And Gene Expression Measurement10/19/2005 5:12:56 PM
Lynx Therapeutics, Inc. (LYNX) Announces 1-For-2 Reverse Stock Split; Reverse Stock Split To Facilitate Post Business Combination New NASDAQ SmallCap Market Listing10/19/2005 5:12:54 PM
Lynx Therapeutics, Inc. (LYNX) Stockholders Overwhelmingly Approve Solexa-Lynx Business Combination10/19/2005 5:12:53 PM
Lynx Therapeutics, Inc. (LYNX) Announces Publication Of Scientific Papers Showcasing Application Of MPSS To Study Stem Cells10/19/2005 5:12:52 PM
Lynx Therapeutics, Inc. (LYNX) Announces Funding By The USDA For Deep Profiling Of Small Rice RNAs By MPSS10/19/2005 5:12:50 PM
Lynx Therapeutics, Inc. (LYNX) Stockholders To Vote On Proposed Solexa Business Combination At Annual Meeting Of Stockholders March 1, 200510/19/2005 5:12:35 PM
Lynx Therapeutics, Inc. (LYNX) Announces Follow Up Contract With Researchers At University of Southern California To Study Oyster Larval Development10/19/2005 5:12:35 PM
Lynx Therapeutics, Inc. (LYNX) Names Mary L. Schramke Acting Chief Executive Officer10/19/2005 5:12:15 PM
Lynx Therapeutics, Inc. (LYNX) Reports 2004 Third Quarter Financial Results; Conference Call To Begin At 5:00 P.M. ET Today10/19/2005 5:12:13 PM
1234
//-->